Try our business solution for free!

NDA/BLA filing to FDA approval times for new drugs in select disease areas 2011-2020

Published by
Matej Mikulic,
Jun 3, 2022
This statistic shows the time from filing to approval for NDA/BLA filings for new drugs in the U.S., in the period from January 1, 2011, to November 30, 2020, by disease area. It was found that new drugs in endocrine and psychiatry took the longest average time to be approved, with an average of 1.8 years.

Time from NDA/BLA filings for new drugs to FDA approval in select disease areas in the U.S. between 2011 and 2020

Exclusive Premium statistic

You need a Statista Account for unlimited access.

  • Full access to 1m statistics
  • Incl. source references
  • Available to download in PNG, PDF, XLS format
Statista Accounts
View for free

Access to this and all other statistics on 80,000 topics from

$468 USD / Year
$708 USD / Year

© Statista 2023
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

February 2021

Region

United States

Survey time period

January 1, 2011, to November 30, 2020

Supplementary notes

Only company-sponsored, FDA registration-enabling development programs were included in this analysis. Investigator-sponsored studies and combinations with other investigational drugs were excluded.
NDA - New Drug Application.
BLA - Biologic License Application.

Citation formats
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 USD $39 USD / Month *
in the first 12 months
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " U.S. pharmaceutical industry "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Statistics on U.S. pharmaceutical industry

Contribution to global pharma

5

Overview

6

Companies

6

Research and development

7

Generics

5

Public view on pharma

6

Outlook

4

Further related statistics

17

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceuticals in IndiaGlobal pharmaceutical industryPrivate equity and venture capital in IndiaState of health in IndiaCoronavirus (COVID-19) in India
Statista Accounts: Access All Statistics. Starting from $468 USD / Year
Learn more about how Statista can support your business.
Menu